VHT
Click for more information
0.00% $1.15 volpara health technologies limited

FDA is reviewing and approving multiple Covid vaccines. They...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. JGraham18
    578 Posts.
    lightbulb Created with Sketch. 175
    clock Created with Sketch.
    18/12/20
    09:34
    Post #: 49671744
    FDA is reviewing and approving multiple Covid vaccines. They have probably put everything else to the backburner and rightfully so. Not Volpara's fault and nothing they can do about it.
    VHT Price at posting: $1.31 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war
right-arrow Created with Sketch.
NVU Nanoveu commences crucial benchmark testing for System-on-aChip (SoC) Semiconductor technology
right-arrow Created with Sketch.
NEWS The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
right-arrow Created with Sketch.
NEWS Trending Thread: $13.0 million Institutional Placement
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
NEWS ClearVue successfully raises $7.5 million via institutional placement
right-arrow Created with Sketch.
watchlist Created with Sketch. Add VHT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.